Fennec Pharmaceuticals Inc (FENC) — Financial Flexibility Index
Fennec Pharmaceuticals Inc (FENC) has a Financial Flexibility Index of 0.00x as of June 2026. Free cash flow of $50.00K (operating CF $50.00K minus capex $0.00) represents 0% of total liabilities ($33.31 Million). Check total reinvestment intensity of Fennec Pharmaceuticals Inc to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Fennec Pharmaceuticals Inc Financial Flexibility Index (1999–2025)
Historical Financial Flexibility Index trend for Fennec Pharmaceuticals Inc across 26 annual periods. For the full cash flow conversion analysis, see Fennec Pharmaceuticals Inc cash flow conversion.
Annual Financial Flexibility Index for Fennec Pharmaceuticals Inc (1999–2025)
Year-by-year free cash flow to debt coverage for Fennec Pharmaceuticals Inc. Explore Fennec Pharmaceuticals Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.36x | $-12.47 Million | $-12.47 Million | $35.02 Million | ▼ -167.1% |
| 2024 | 0.53x | $26.98 Million | $26.98 Million | $50.82 Million | ▲ +219.2% |
| 2023 | -0.45x | $-17.14 Million | $-17.14 Million | $38.49 Million | ▲ +27.2% |
| 2022 | -0.61x | $-18.06 Million | $-18.06 Million | $29.51 Million | ▲ +71.4% |
| 2021 | -2.14x | $-14.22 Million | $-14.22 Million | $6.64 Million | ▲ +67.8% |
| 2020 | -6.64x | $-15.60 Million | $-15.60 Million | $2.35 Million | ▼ -66.6% |
| 2019 | -3.99x | $-9.06 Million | $-9.06 Million | $2.27 Million | ▲ +16.6% |
| 2018 | -4.78x | $-7.83 Million | $-7.83 Million | $1.64 Million | ▼ -115.9% |
| 2017 | -2.21x | $-3.64 Million | $-3.64 Million | $1.64 Million | ▲ +58.1% |
| 2016 | -5.28x | $-2.12 Million | $-2.12 Million | $402.00K | ▼ -33.7% |
| 2015 | -3.95x | $-1.86 Million | $-1.86 Million | $471.00K | ▼ -309.3% |
| 2014 | -0.97x | $-1.70 Million | $-1.70 Million | $1.76 Million | ▼ -40.2% |
| 2013 | -0.69x | $-2.21 Million | $-2.21 Million | $3.21 Million | ▼ -68.5% |
| 2012 | -0.41x | $-2.99 Million | $-2.99 Million | $7.32 Million | ▼ -25.3% |
| 2011 | -0.33x | $-1.79 Million | $-3.23 Million | $5.47 Million | ▼ -84.8% |
| 2010 | -0.18x | $-1.93 Million | $-1.93 Million | $10.92 Million | ▲ +98.4% |
| 2009 | -10.98x | $-4.69 Million | $-4.69 Million | $427.00K | ▼ -205.9% |
| 2008 | -3.59x | $-10.79 Million | $-10.81 Million | $3.01 Million | ▲ +17.0% |
| 2007 | -4.32x | $-13.23 Million | $-13.30 Million | $3.06 Million | ▼ -188.8% |
| 2006 | -1.50x | $-13.47 Million | $-13.47 Million | $9.00 Million | ▼ -3.3% |
| 2005 | -1.45x | $-12.16 Million | $-12.26 Million | $8.39 Million | ▼ -116.9% |
| 2003 | -0.67x | $-5.83 Million | $-5.99 Million | $8.73 Million | ▼ -28.9% |
| 2002 | -0.52x | $-5.36 Million | $-5.43 Million | $10.35 Million | ▲ +87.0% |
| 2001 | -3.98x | $-2.93 Million | $-3.23 Million | $736.04K | ▼ -7.3% |
| 2000 | -3.71x | $-2.36 Million | $-2.69 Million | $635.41K | ▼ -85.7% |
| 1999 | -2.00x | $-1.19 Million | $-1.22 Million | $596.46K | — |